Product Overview

Dacomitinib (PF299804) is a highly selective, irreversible tyrosine kinase inhibitor primarily used in the research and development of anti-tumor drugs, and is widely used in the treatment of EGFR-mutant non-small cell lung cancer. As a pharmaceutical intermediate, this product is suitable for small-scale preparation, pilot-scale amplification, and commercial production stages in the early stages of drug development, meeting diverse needs from laboratory research to industrialization, and is a key structural unit in the process of innovative drug development.

Applications

• Drug synthesis intermediates used in anti-tumor drug development
• Used for process optimization and route development of EGFR target inhibitors
• Serves as a key raw material for preclinical research and formulation development
• Supports customized synthesis and process improvement projects
• Applicable to drug impurity research and quality control system construction

Quality & Supply Capability

English Name: Dacomitinib (PF299804) Properties: White to off-white crystalline powder with good chemical stability. Contains multiple functional groups, suitable for various organic synthesis reactions, and meets pharmaceutical intermediate standards. Storage Recommendations: Store in a sealed, light-protected, and dry place, subject to the COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process service from sample supply, small-scale preparation, pilot-scale amplification to customized batch production. We can flexibly formulate supply solutions according to customers' specific requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documents. Simultaneously, we have a professional technical support team to assist customers in completing process optimization and project transformation from laboratory R&D to large-scale production, ensuring stable product quality, timely delivery, and efficient service.

Why Choose Bioncan

Focused on pharmaceutical intermediates, with extensive experience in anti-tumor drug synthesis. Full-scale supply capabilities, covering needs from laboratory to commercial production. Provides complete quality testing documentation to ensure product compliance and traceability. Supports customized needs, meeting the specific specifications and technical requirements of different customers. Comprehensive process optimization and scale-up technical support to help customers accelerate their R&D process.

Online Consulting

For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 1110813-31-4, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.